COVID-19 : reminder of the risks of chloroquine and hydroxychloroquine
EMA is reminding healthcare professionals to closely monitor patients with COVID-19 who are receiving chloroquine or hydroxychloroquine, given the serious side effects that can result from treatment with these medicines.